The progressive replacement of epithelial E-cadherin with mesenchymal N-cadherin, termed a cadherin switch, has recently been shown to be critical for OSCC tumor progression, in both a mouse model and human OSCC samples [124]. Here, CDH2 is linked to neoplasm.